Research

Energy balance

Adjuvant chemotherapy for breast cancer causes weight gain primarily through reduced physical activity and sarcopenic obesity (fat gain with lean mass loss), not through increased caloric intake.

If you are gaining weight during breast cancer chemotherapy, do not blame yourself for eating too much. Research shows that caloric intake does not significantly increase during this time. Instead, the weight gain is driven by a drop in physical activity and a loss of muscle mass (sarcopenic obesity). The most effective intervention is to increase physical activity, specifically resistance training for the legs, to preserve muscle and prevent fat gain.

GoodRefutesHIGH confidence
These data do not support overeating as a cause of weight gain among breast cancer patients who receive CT. The data suggest, however, that CT-induced weight gain is distinctive and indicative of sarcopenic obesity (weight gain in the presence of lean tissue loss or absence of lean tissue gain). The development of sarcopenic obesity with evidence of reduced physical activity supports the need for interventions focused on exercise, especially resistance training in the lower body, to prevent weight gain.
Wendy Demark‐Wahnefried et al. · Journal of Clinical Oncology · 2001

Why this rating

Prospective controlled trial with validated measures (DEXA, indirect calorimetry, dietary recalls) and a reasonable sample size (N=53), though limited by modest size.

Source

Changes in Weight, Body Composition, and Factors Influencing Energy Balance Among Premenopausal Breast Cancer Patients Receiving Adjuvant Chemotherapy

Wendy Demark‐Wahnefried et al. · Journal of Clinical Oncology · 2001

DOI 10.1200/jco.2001.19.9.2381

cohort · n=53Cited 546×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →